STD Testing Market (Sexually Transmitted Diseases Testing Market) is expected to garner $167.4 billion by 2020, registering a CAGR of 8.5% during the forecast period 2014-2020.

Portland, OR -- (SBWire) -- 02/21/2018 --The increasing prevalence and incidence of STDs will increase the demand for diagnostic testing of STDs. However, a there are factors that are likely to restrain the STD testing market growth. It is estimated that the impact of the drivers is likely to be higher than the restraints; the global STD testing market is likely to grow at CAGR of 8.5% during the forecast period. Additionally, a cumulative effect of the drivers and the restraints is likely to reveal few niche market opportunities that can be capitalized by companies supplying STD diagnostic tests, supplies and equipment providers and public and private labs proving beneficial for the expansion of STD testing market at a global level.

Get PDF Brochure For Details: https://www.alliedmarketresearch.com/request-sample/385

Allied Market Research published a report titled "Global Market for Diagnostic Testing of Sexually Transmitted Diseases (STDs) (Disease Types, Testing Volume, Testing Devices and Geography) - Industry Analysis and Forecast, 2013 – 2020." As per the report, the diagnostic testing market for sexually transmitted diseases would attain a size of $167.4 billion by the year 2020 with an 8.5% CAGR during 2014-2020. This significant increase of the market value is due to rise in the cases of HPV and HIV testing in African and Asia-Pacific region.

Enquiry About Report: https://www.alliedmarketresearch.com/purchase-enquiry/385

The factors driving the growth of this market are increasing fatal STDs along with high cost, and constant employment of Client-Initiated Counselling and Testing (CICT) & Provider-Initiated Counselling and Testing (PICT). Clinical manifestation of STD such as Chlamydia includes Urethritis, Orchitis, Epididymitis, and Infertility in men to Endometritis, Cervicitis, PID, infertility, Perihepatitis and Salpingitis in women.

There is a 40% chance that Chlamydia would be infected to female from male; and a 30% chance that it will infected in male from female Hence, to curb such incidence, healthcare sector globally initiates national screening programmes and also provides incentives for voluntary screening. Thus, it leads to high test volume for Chlamydia and increases its market share.

Buy Now (Report on Discount): https://www.alliedmarketresearch.com/checkout/488633